Zobrazeno 1 - 10
of 147
pro vyhledávání: '"spd-1"'
Autor:
Lei Liu, Pengpeng Lan, Guiping Wu, Xiaojie Zhu, Hongfeng Shi, Yan Li, Ruili Li, Ling Zhao, Juan Xu, Min Xu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Patients with traumatic brain injury (TBI) frequently exhibit concomitant immunosuppression. In this study, we evaluated the predictive values of soluble programmed death-1 (sPD-1) and soluble programmed death ligand-1 (sPD-L1) in patients w
Externí odkaz:
https://doaj.org/article/bc17a2613baa4536a37d01a8a4778fd8
Autor:
Tatiana N. Zabotina, Antonina I. Chertkova, Anna A. Borunova, Nikolay E. Kushlinskii, Elena S. Gershtein, Elena N. Zakharova, Esma K. Shoua, Vasily T. Tsiklauri, Igor V. Samoylenko, Maxim V. Khoroshilov, Zaira G. Kadagidze
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 301-307 (2023)
Background. The PD-1/PD-L1 pathway plays an important role in tumor evasion from immunological surveillance. In addition to the membrane forms of PD-1 and PD-L1, there are soluble variants: sPD-1 and sPD-L1. Both membrane and soluble forms have immun
Externí odkaz:
https://doaj.org/article/03217cc7200040a588ddd35a922d7771
Autor:
I. S. Stilidi, O. V. Kovaleva, A. N. Gratchev, E. M. Tchevkina, P. A. Podlesnaya, P. V. Tsarapaev, E. A. Suleymanov, N. E. Kushlinskii
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 3, Pp 96-104 (2022)
Background. Implementation of immunotherapy in clinical oncological practice has significantly improved the results of cancer treatment. It resulted in the need for seeking new markers to assess the effectiveness of therapy and the disease prognosis.
Externí odkaz:
https://doaj.org/article/0eebef41557c48d7b1cd4982a01e79c9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pham Thi Minh Huyen, Dang Thi Ngoc Dung, Peter Johann Weiß, Phan Quoc Hoan, Dao Phuong Giang, Ngo Thi Uyen, Nguyen Van Tuan, Ngo Tat Trung, Thirumalaisamy P. Velavan, Le Huu Song, Nghiem Xuan Hoan
Publikováno v:
International Journal of Infectious Diseases, Vol 115, Iss , Pp 229-236 (2022)
ABSTRACT: Background: Programmed cell death-1 (PD-1) variants and circulating level of soluble PD-1 are associated with susceptibility to malignant and infectious disease. This study aimed to examine the association of PD-1.5 and PD-1.9 variants, and
Externí odkaz:
https://doaj.org/article/90801cb22fb74e79aa216dc331363057
Publikováno v:
BMC Immunology, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Previous studies have indicated that the programmed death molecule 1 (PD-1) signaling pathway may play a key role in rheumatoid arthritis (RA). However, the pathogenesis of rheumatoid arthritis-related interstitial lung disease (R
Externí odkaz:
https://doaj.org/article/867175a9054540c4b111e0c9560b5e10
Autor:
Olga V. Kovaleva, Polina A. Podlesnaya, Alexei N. Gratchev, Viktor L. Chang, Nikolai A. Ognerubov, Nikolai E. Kushlinskii
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 122-127 (2021)
Stomach cancer is one of the most common tumors of the gastrointestinal tract. In Russia, stomach cancer is ranked fourth in incidence among malignancies and gives ground for lung, breast and colon cancers. Although the success of PD-1/PD-L1 inhibito
Externí odkaz:
https://doaj.org/article/e415a458b020461d865ff5e5ab64b4b7
Autor:
Wenjiao Xia, Jiaxin Chen, Wenqing Hou, Junsheng Chen, Ying Xiong, Hongyan Li, Xin Qi, Hui Xu, Zuoquan Xie, Mingfeng Li, Xiaomin Zhang, Jing Li
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6843 (2023)
A new therapy strategy for relapsing patients who have received trastuzumab treatment urgently needs to be explored. HER2-specific chimeric antigen receptor (CAR)-expressing NK cells are being rapidly developed for solid tumor therapy, as they have m
Externí odkaz:
https://doaj.org/article/30c9bc743cce46a1a0b70dcbca3e9ac8